» Articles » PMID: 33379248

Curcumin Metabolite Tetrahydrocurcumin in the Treatment of Eye Diseases

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Dec 31
PMID 33379248
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Curcumin is one of the most valuable natural products due to its pharmacological activities. However, the low bioavailability of curcumin has long been a problem for its medicinal use. Large studies have been conducted to improve the use of curcumin; among these studies, curcumin metabolites have become a relatively new research focus over the past few years. Additionally, accumulating evidence suggests that curcumin or curcuminoid metabolites have similar or better biological activity than the precursor of curcumin. Recent studies focus on the protective role of plasma tetrahydrocurcumin (THC), a main metabolite of curcumin, against tumors and chronic inflammatory diseases. Nevertheless, studies of THC in eye diseases have not yet been conducted. Since ophthalmic conditions play a crucial role in worldwide public health, the prevention and treatment of ophthalmic diseases are of great concern. Therefore, the present study investigated the antioxidative, anti-inflammatory, antiangiogenic, and neuroprotective effects of THC on four major ocular diseases: age-related cataracts, glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR). While this study aimed to show curcumin as a promising potential solution for eye conditions and discusses the involved mechanistic pathways, further work is required for the clinical application of curcumin.

Citing Articles

Bioinformatic Analysis of the Significance of the KIR2DL4 Gene in Recurrent Implantation Failure.

Zhang X, Zhang Z, Liu Y, Zhou L, Hu Y, Zhang C Biochem Genet. 2024; .

PMID: 38858283 DOI: 10.1007/s10528-024-10857-8.


Anti-inflammatory effect of curcuminoids and their analogs in hyperosmotic human corneal limbus epithelial cells.

Kasetsuwan N, Reinprayoon U, Uthaithammarat L, Sereemaspun A, Sae-Liang N, Chaichompoo W BMC Complement Med Ther. 2024; 24(1):172.

PMID: 38654265 PMC: 11040938. DOI: 10.1186/s12906-024-04448-8.


Developments in Emerging Topical Drug Delivery Systems for Ocular Disorders.

Mandal S, Vishvakarma P, Bhumika K Curr Drug Res Rev. 2023; 16(3):251-267.

PMID: 38158868 DOI: 10.2174/0125899775266634231213044704.


Paradoxical expression of NRP1 in decidual stromal and immune cells reveals a novel inflammation balancing mechanism during early pregnancy.

Chen J, Li Y, Xu L, Sang Y, Li D, Du M Inflamm Res. 2023; 72(7):1341-1357.

PMID: 37328599 DOI: 10.1007/s00011-023-01734-y.


Three Major Causes of Metabolic Retinal Degenerations and Three Ways to Avoid Them.

Kovacs-Valasek A, Rak T, Postyeni E, Csutak A, Gabriel R Int J Mol Sci. 2023; 24(10).

PMID: 37240082 PMC: 10218427. DOI: 10.3390/ijms24108728.


References
1.
Chan T, Wilkinson Berka J, Deliyanti D, Hunter D, Fung A, Liew G . The role of reactive oxygen species in the pathogenesis and treatment of retinal diseases. Exp Eye Res. 2020; 201:108255. DOI: 10.1016/j.exer.2020.108255. View

2.
Ellwein L, Kupfer C . Strategic issues in preventing cataract blindness in developing countries. Bull World Health Organ. 1995; 73(5):681-90. PMC: 2486813. View

3.
Loboda A, Damulewicz M, Pyza E, Jozkowicz A, Dulak J . Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016; 73(17):3221-47. PMC: 4967105. DOI: 10.1007/s00018-016-2223-0. View

4.
Flaxman S, Bourne R, Resnikoff S, Ackland P, Braithwaite T, Cicinelli M . Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017; 5(12):e1221-e1234. DOI: 10.1016/S2214-109X(17)30393-5. View

5.
Forsythe J, Jiang B, Iyer N, Agani F, Leung S, Koos R . Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996; 16(9):4604-13. PMC: 231459. DOI: 10.1128/MCB.16.9.4604. View